Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaounde, Cameroon

CA Hankins; S Koulla-Shiro; P Kilmarx; G Ferrari; M Schechter; CT Kane; F Venter; Charles Boucher; AL Ross; D Zewdie; SP Eholie; E Katabira

doi:10.3851/imp3165

Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaounde, Cameroon

CA Hankins
, S Koulla-Shiro
, P Kilmarx
, G Ferrari
, M Schechter
, CT Kane
, F Venter
, Charles Boucher
, AL Ross
, D Zewdie
, SP Eholie
, E Katabira

Virology

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	179-184
Number of pages	6
Journal	Antiviral Therapy
Volume	22
Issue number	2
DOIs	https://doi.org/10.3851/imp3165
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC OR-01

Access to Document

10.3851/imp3165

http://hdl.handle.net/1765/100245

Cite this

@article{2638d6c3f8684f0d996de221d635fd57,

title = "Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaounde, Cameroon",

author = "CA Hankins and S Koulla-Shiro and P Kilmarx and G Ferrari and M Schechter and CT Kane and F Venter and Charles Boucher and AL Ross and D Zewdie and SP Eholie and E Katabira",

year = "2017",

doi = "10.3851/imp3165",

language = "Undefined/Unknown",

volume = "22",

pages = "179--184",

journal = "Antiviral Therapy",

issn = "1359-6535",

publisher = "SAGE Publications",

number = "2",

}

TY - JOUR

T1 - Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaounde, Cameroon

AU - Hankins, CA

AU - Koulla-Shiro, S

AU - Kilmarx, P

AU - Ferrari, G

AU - Schechter, M

AU - Kane, CT

AU - Venter, F

AU - Boucher, Charles

AU - Ross, AL

AU - Zewdie, D

AU - Eholie, SP

AU - Katabira, E

PY - 2017

Y1 - 2017

U2 - 10.3851/imp3165

DO - 10.3851/imp3165

M3 - Article

SN - 1359-6535

VL - 22

SP - 179

EP - 184

JO - Antiviral Therapy

JF - Antiviral Therapy

IS - 2

ER -